News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

GSK Changes Will Not Impact Supply of Medicines

May 17 2005

GSK Confirms Proposed Changes Will Not Impact Supply of Current GSK Medicines in New Zealand Or Ongoing Clinical Trials

GSK Pharmaceuticals New Zealand has decided to change the way its business is structured in New Zealand. These proposed changes are the result of an in-depth analysis of the business environment in New Zealand.

GSK Pharmaceuticals is committed to retaining a presence in New Zealand and to working constructively with government and healthcare professionals in order to help meet the twin challenges of developing alternative models which can increase access to important medicines, while recognising the need for cost containment.

We are currently talking through the proposed changes with our team and we should be in a position to provide you with more details at the end of May, once formal consultation has been completed.

GSK Pharmaceuticals can confirm that these proposed changes will not impact the supply of current GSK medicines in New Zealand.

GSK invests approximately $6.7 million per year in New Zealand on the research and development of new medicines. GSK does have on-going clinical trials in NZ and these will not be affected by these changes.

As you will appreciate, we are working through a difficult period with our team at the moment. As a result, this is our focus at the present time and we are unable to comment further.

These changes do not affect GSK Consumer (New Zealand).

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
K Emma Ng's Old Asian, New Asian

This book, written by a young second-generation Chinese New Zealander, gives many examples of the racism that Asian New Zealanders experience. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION